Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,100
-550 (-4.72%)
At close: Apr 9, 2026

Bio Solution Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2020FY 2019
Period Ending
Apr '26 Dec '25 Dec '24 Dec '20 Dec '19
272,665191,204172,508234,764341,961
Market Cap Growth
28.65%10.84%-26.52%-31.35%-
Enterprise Value
291,482210,628137,327198,721-
Last Close Price
11280.007910.007166.679816.6714400.00
PE Ratio
997.46699.46---
PS Ratio
17.9412.5813.3930.3238.50
PB Ratio
8.525.975.525.037.11
P/TBV Ratio
8.766.145.655.127.24
EV/Sales Ratio
19.1813.8610.6625.66-
Debt / Equity Ratio
0.970.971.010.030.02
Net Debt / Equity Ratio
0.590.590.55-0.74-0.83
Net Debt / EBITDA Ratio
-8.70-8.70-5.4222.74119.93
Net Debt / FCF Ratio
-12.57-12.57-6.4311.308.30
Asset Turnover
0.220.22-0.15-
Inventory Turnover
4.104.10-3.77-
Quick Ratio
0.530.530.5719.3015.67
Current Ratio
0.570.570.6320.1415.93
Return on Equity (ROE)
0.86%0.86%--3.80%-
Return on Assets (ROA)
-3.99%-3.99%--4.10%-
Return on Capital Employed (ROCE)
-12.70%-12.70%-14.90%-7.00%-3.80%
Earnings Yield
0.10%0.14%-6.92%-0.77%-0.20%
FCF Yield
-0.55%-0.78%-1.55%-1.31%-1.40%
Buyback Yield / Dilution
-3.91%-3.33%-0.66%-1.29%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.